References
Urzua CA (2019) Vogt–Koyanagi–Harada disease. Intechopen. https://doi.org/10.5772/intechopen.85261
Read RW, Rechodouni A, Butani N, Johnston R et al (2001) Complications and prognostic factors in Vogt–Koyanagi–Harada disease. Am J Ophthalmol 131:599–606
Lai T, Chan R, Chan C, Lam D (2009) Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt–Koyanagi–Harada disease. Eye (Lond) 23(3):543–548
Mota LA, Santos AB (2010) Vogt–Koyanagi–Harada syndrome and its multisystemic effects. Rev Med Bras 56:590–595
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647–652
International Team for the Revision of the International Criteria for Behcet’s Disease Evaluation of the International Criteria for Behcet’s disease (ICBD) (2006) Clin Exp Rheumatol 24(supplement 42):S13
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain research including human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from the patient included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Radic, B., Vukojevic, N., Petelin Gadze, Z. et al. Vogt–Koyanagi–Harada syndrome: importance of early treatment. Acta Neurol Belg 120, 1217–1219 (2020). https://doi.org/10.1007/s13760-020-01273-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-020-01273-x